Indegene's Q1 FY 2025-26 Quarterly Results

Result Summary

• Indegene Ltd reported a 12.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 12.0%.
• Its expenses for the quarter were up by 11.6% QoQ and 8.9% YoY.
• The net profit increased 22.8% QoQ and increased 32.7% YoY.
• The earnings per share (EPS) of Indegene Ltd stood at 4.8 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Indegene Ltd is a global healthcare solutions provider that specializes in delivering innovative and integrated healthcare solutions. The company primarily focuses on offering services in areas such as healthcare technology, analytics, and clinical research. Indegene is known for its expertise in commercial analytics, medical affairs, and digital marketing for life sciences companies. As of the latest available data, there have been no major developments or announcements from Indegene that significantly alter their operational focus or market positioning.

Revenue

In the first quarter of fiscal year 2026 (Q1FY26), Indegene Ltd reported a total income of ₹782.90 crores, which represents an increase of 12.5% on a quarter-over-quarter (QoQ) basis compared to ₹696.20 crores in the fourth quarter of fiscal year 2025 (Q4FY25). This also marks a year-over-year (YoY) growth of 12.0% from ₹699.00 crores reported in the first quarter of fiscal year 2025 (Q1FY25). The consistent increase in revenue indicates a positive trajectory in the company's income generation capabilities during this period.

Profitability

For Q1FY26, Indegene Ltd's profit before tax was ₹152.10 crores, showing a QoQ growth of 13.9% from ₹133.50 crores in Q4FY25, and a YoY growth of 27.2% from ₹119.60 crores in Q1FY25. The tax expenses for the quarter amounted to ₹35.70 crores, reflecting a decrease of 7.8% QoQ from ₹38.70 crores, while on a YoY basis, the tax increased by 11.9% from ₹31.90 crores. Consequently, the profit after tax rose to ₹116.40 crores, marking a substantial QoQ increase of 22.8% from ₹94.80 crores and a YoY rise of 32.7% from ₹87.70 crores. Earnings per share for the quarter stood at ₹4.80, indicating a QoQ increase of 14.3% from ₹4.20 and a YoY increase of 26.3% from ₹3.80.

Operating Metrics

Total expenses for Indegene Ltd in Q1FY26 were reported at ₹630.80 crores, which is an increase of 11.6% QoQ from ₹565.10 crores in Q4FY25 and an 8.9% YoY rise from ₹579.40 crores in Q1FY25. The increase in expenses aligns with the growth in revenue, suggesting expanded operational activities. The company's operating metrics reflect a robust performance during the quarter, with significant growth in both income and profit while managing expenses efficiently. This operational efficiency is evident from the substantial increase in profitability metrics such as profit before tax and profit after tax, alongside the reported earnings per share growth.